EO Charging Recognized by Frost & Sullivan with the Product Leadership Award for Enabling Energy Efficiency, Cost-effectiveness, and Grid Reliability in Fleet Charging and Energy Management
EO's smart charging hardware and intelligent charging and energy management software provide…
Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 2041
COMMACK, NY and TAMPA, FL, Dec. 10, 2024 (GLOBE NEWSWIRE) -- SCIENTURE,…
Ness Digital Engineering Acquires Raja Software Labs (RSL), a Silicon Valley-based product engineering company specializing in high volume mobile, web and IoT applications
NEW YORK, Dec. 4, 2024 /PRNewswire/ -- Ness Digital Engineering (Ness) , a…
Silynxcom Enhancing Drone Sound Awareness for Armored Vehicle Crews with Upgraded New Product
December 02, 2024 09:05 ET | Source: Silynxcom Ltd. Netanya, Israel, Dec.…
Freudenberg strengthens commitment to India with new product launches at CPhI & PMEC 2024
Launches Single-Use Assemblies & ASTC UV-Shield Tubing for Indian customersNEW DELHI, Nov. 26,…
Innovations and Product Updates Unveiled at Deltek ProjectCon 2024
HERNDON, Va., Nov. 13, 2024 /PRNewswire/ -- Deltek, the leading global provider of…
BioAdaptives, Inc. Announces Complete Product Overhaul with New Line of Scientifically Advanced Solutions
LAS VEGAS, Nov. 13, 2024 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc.…
FDA Reauthorizes Swedish Matchs General snus as a Modified Risk Tobacco Product
Philip Morris International affiliate, Swedish Match, earned first-ever FDA authorization for a…
CarbonChain has received third-party validation for its latest Corporate Carbon Footprint Accounting and Reporting Methodology and Product Carbon Footprint Accounting and Reporting Methodology
- and additional sector-specific methodologies for oil & gas, transport, and metals…
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting
Novel H2CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on…